$28M award in hormone suit

Wall Street Journal, November 25, 2009

A jury awarded $28 million in punitive damages in Pennsylvania state court to a plaintiff who claimed her use of Pfizer Inc.'s hormone-therapy drugs caused breast cancer. The jury had awarded $6.3 million in compensatory damages to the plaintiff, Donna Kendall, of Decatur, IL. The jury found that Pfizer units had engaged in a pattern of willful and reckless conduct. Wyeth was the primary seller of hormone-therapy drugs, and Pfizer recently acquired the company. A separate Pfizer unit, Upjohn, was a defendant in the case.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.